Isogenica Ltd - News/Media - Leaders in molecular evolution & peptide therapeutics

News

6^thMay 2008 - Isogenica completes acquisition of the principal assets of Karyon CTT

6^th June 2007 - Isogenica Enters Into Research and License Agreement With Wyeth

6^thNovember 2006 - Isogenica enters into a research and licence option agreement with UCB

13^thJuly 2006 - Isogenica Renews Research Collaboration with AstraZeneca

15^thJune 2006 - Isogenica announces the appointment of two non-executive directors

8^thMay 2006 - Isogenica Enters into Research Collaboration with GE Healthcare

1^stMarch 2006 - Isogenica closes new round of funding

7^thNovember 2005 - Isogenica enters into research collaboration with Amgen

17^thJanuary 2005 - Isogenica enters into research collaboration with NeuroTargets Ltd.

19^thMay 2004 - Isogenica enters into a research collaboration with AstraZeneca

19^thMarch 2004 - Isogenica publishes key paper describing its proprietary CIS display in PNAS

13^thMarch 2004 - Isogenica enters into a license and option agreement with Sangamo Biosciences

10^thDecember 2003 - Isogenica signs an evaluation agreement with Johnson & Johnson Pharmaceuticals

7^thMay 2003 - Isogenica signs an exclusive enabling agreement with Smiths Detection

8^thJuly 2002 - Isogenica enters research collaboration with Graseby Dynamics

20^thMay 2002 - Invitrogen signs option agreement to license Isogenica’s covalent display technology

1^stOct 2001 - Affitech and Isogenica agree exclusive license to novel discovery technology for human antibodies

1^stApril 2001 - Isogenica announces launch of company.